Search - tctmd.com

Displaying 21 - 40 of 167

Sort: Relevancy | Date

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

Presentation TCT 2019

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

Presenter: Suzanne Baron

September 29, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Shelley Wood

September 29, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Presentation TCT 2019

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Presentation TCT 2019

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Presentation TCT 2019

Combined Low-Flow, Low-Gradient Aortic Stenosis and Functional Mitral Regurgitation: A Diagnostic Challenge

Presenter: Rebecca Hahn

September 28, 2019

Presentation TCT 2019

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Vinod Thourani

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Presentation TCT 2019

Hypertrophic Myopathy and Aortic Stenosis: How to Manage?

Presenter: Michel Pansieri

September 28, 2019

Presentation TCT 2019

TCT 5: Is Surgical Aortic Valve Replacement Still an Option for Radiation-induced Aortic Stenosis in Transcatheter Aortic Valve Replacement Era?

Presenter: Farhang Yazdchi

September 28, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

Presentation TCT 2019

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

Presenter: Michael Mack

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

Prospective Single-Arm Clinical Investigation for the Treatment of Subjects With Severe Symptomatic Aortic Valve Stenosis Using Valvosoft® Pulsed Cavitational Ultrasound Therapy (PCUT): First-in-Man

Presenter: Peter den Heijer, MD

September 27, 2019

Presentation TCT 2019

Cardiac Output and Cerebral Blood Flow Improvement in Patients With Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation

Presenter: Wieneke Vlastra

September 27, 2019

Presentation TCT 2019

PORTICO: A Randomized Trial of Portico vs. Commercially Available Transcatheter Aortic Valves in Patients With Severe Aortic Stenosis

Presenter: Gregory Fontana

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

Advertisement

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Combined Low-Flow, Low-Gradient Aortic Stenosis and Functional Mitral Regurgitation: A Diagnostic Challenge

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Hypertrophic Myopathy and Aortic Stenosis: How to Manage?

TCT 5: Is Surgical Aortic Valve Replacement Still an Option for Radiation-induced Aortic Stenosis in Transcatheter Aortic Valve Replacement Era?

Portico Noninferior to Commercial TAVR Valves in IDE Study

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Prospective Single-Arm Clinical Investigation for the Treatment of Subjects With Severe Symptomatic Aortic Valve Stenosis Using Valvosoft® Pulsed Cavitational Ultrasound Therapy (PCUT): First-in-Man

Cardiac Output and Cerebral Blood Flow Improvement in Patients With Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation

PORTICO: A Randomized Trial of Portico vs. Commercially Available Transcatheter Aortic Valves in Patients With Severe Aortic Stenosis

TCT 2019 Day Two: Transcatheter Valves, New and Old

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content